| Literature DB >> 33303869 |
Yifeng Nie1,2,3, Yin He1,4, Dong Han2,3, Yuansheng Liu5, Xiang Li6,7.
Abstract
The prevalence of arrhythmia in patients with hypertension has gradually attracted widespread attention. However, the relationship between hypertension and arrhythmia still lacks more attention. Herein, we explore the biomechanical mechanism of arrhythmia in hypertensive rats and the effect of amiodarone on biomechanical properties. We applied micro-mechanics and amiodarone to stimulate single ventricular myocytes to compare changes of mechanical parameters and the mechanism was investigated in biomechanics. Then we verified the expression changes of genes and long non-coding RNAs (lncRNAs) related to myocardial mechanics to explore the effect of amiodarone on biomechanical properties. The results found that the stiffness of ventricular myocytes and calcium ion levels in hypertensive rats were significantly increased and amiodarone could alleviate the intracellular calcium response and biomechanical stimulation. In addition, experiments showed spontaneously hypertensive rats were more likely to induce arrhythmia and preoperative amiodarone intervention significantly reduced the occurrence of arrhythmias. Meanwhile, high-throughput sequencing showed the genes and lncRNAs related to myocardial mechanics changed significantly in the spontaneously hypertensive rats that amiodarone was injected. These results strengthen the evidence that hypertension rats are prone to arrhythmia with abnormal myocardial biomechanical properties. Amiodarone effectively inhibit arrhythmia by improving the myocardial biomechanical properties and weakening the sensitivity of mechanical stretch stimulation.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33303869 PMCID: PMC7730129 DOI: 10.1038/s41598-020-78677-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The effect and mechanism of amiodarone on ventricular myocytes in vitro. (a) Stiffness variation trend of ventricular myocytes in SHR and WKY at different indentation depths. (b) Young's modulus of SHR ventricular myocytes vs. Young's modulus of WKY ventricular myocytes. (c) Comparision of amiodarone's effect on the stiffness of ventricular myocytes in SHR group and WKY group: amiodarone was given within the second minute, Young's modulus of both groups decreased, but SHR decreased more significantly. (d) Comparison of amiodarone's effect on the stiffness of ventricular myocytes in SHR group and WKY group: amiodarone was given within the second minute, the average fluorescence intensity of both groups decreased, but the average fluorescence intensity of SHR group decreased more significantly. (e) Effect of amiodarone on stiffness of ventricular myocytes: comparison of stiffness before and after amiodarone added. (f) Effect of amiodarone on ventricular myocyte stiffness under streptomycin blocked. (g) Changes of intracellular Ca2+ concentration in ventricular myocytes in resting state and rhythmic contracting state. (h) The effect and mechanism of amiodarone on intracellular Ca2+ concentration in ventricular myocytes in resting state and rhythmic contracting state.
Figure 2The effect of amiodarone on the animals in vivo. (a) Left ventricular pressure and electrocardiogram before aortic ligation in WKY group. (b) Left ventricular pressure and electrocardiogram before aortic ligation in SHR group. (c) Left ventricular pressure and electrocardiogram after aortic ligation in WKY group. (d) Left ventricular pressure and electrocardiogram after aortic ligation in SHR group. (e) Comparison of arterial pressure and left ventricular pressure between SHR and WKY rats. (f) Comparison of cardiac hypertrophy index between SHR and WKY rats.The total number of acute arrhythmias occurred within 5 min after coarctation of aortic arch for rapidly ascending hypertension (*representing P < 0.05, * * stands for P < 0.01, * * * represents P < 0.001).
Figure 3Effects of amiodarone on genes and lncRNAs expression. (a) Volcano plots of SHR group in arrhythmia treated with amiodarone. (b) Volcano plots of WKY group with arrhythmia treated with amiodarone. (c) GO analysis diagram for comparison of lncRNAs before and after amiodarone treatment in SHR group, green parts indicated biological processes and the red represented cellular components, and the yellow represented molecular functions. In addition, the black represented the number of related genes. (d) The cluster diagram of differential gene expression patterns. Column and row respectively represents experimental samples and the degree of gene expression in different samples: red means a relatively high expression and navy blue means low expression level. The sample tree on the top represents the similarity clustering relationship among the samples and the gene tree on the left represents the expression-similarity clustering relationship between genes[22].
Expression differences of genes related to cardiac mechanics in SHR group after amiodarone treatment and 12 biological processes related to cardiac mechanics.
| Biological processes related to cardiac mechanics | Number | P value | Name of participating gene |
|---|---|---|---|
| Positive regulation of striated muscle contraction | 2 | 0.007 | Ptgs2;Hsp90aa1 |
| Positive regulation of vasoconstriction | 2 | 0.008 | Fgg;Ptgs2 |
| Vascular morphology | 5 | 0.022 | C3;Ntrk2;Ptgs2;Hmox1;C6 |
| Positive Regulation of Smooth Muscle Cell Proliferation | 2 | 0.023 | Ptgs2;Hmox1 |
| Regulation of vasoconstriction | 2 | 0.026 | Fgg;Ptgs2 |
| Blood pressure regulation | 3 | 0.027 | Ptgs2;Hmox1;Nrg1 |
| Positive regulation of myocardial contraction | 1 | 0.028 | Hsp90aa1 |
| Vascular development | 5 | 0.038 | C3;Ntrk2;Ptgs2;Hmox1;C6 |
| Positive regulation of circulatory system | 2 | 0.044 | Fgg;Ptgs2 |
| Intracellular calcium signaling | 1 | 0.044 | Ntrk2 |
| Circulating system regulation | 3 | 0.045 | Fgg;Ptgs2;Hsp90aa1 |
| Vasoconstriction | 2 | 0.046 | Fgg;Ptgs2 |